Glutathione S-transferase activity and subunit composition in transitional cell cancer and mucosa of the human bladder

Urology

Volumn 49, Issue 4, 1997, Pages 644-651

  Berendsen, Chris L ^a   Peters, Wilbert H M ^a   Scheffer, Peter G ^a   Bouman, Anneke A ^a   Boven, Epie ^a   Newling, Don W W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ARTICLE; BLADDER CANCER; BLADDER MUCOSA; CELL METABOLISM; CYTOTOXICITY; DETOXIFICATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MUCOUS MEMBRANE; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0030939403     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00575-4     Document Type: Article

References (47)

1. Lum BL, Torti FM. Adjuvant intravesical pharmacotherapy for superficial bladder cancer. J Natl Cancer Inst. 83:1991;682-694.
2. Lamm DL, Riggs DR, Traynelis CL, Nseyo UO. Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder. J Urol. 153:1995;1444-1450.
3. Black SM, Wolf CR. The role of glutathione-dependent enzymes in drug resistance. Pharmacol Ther. 51:1991;139-154.
4. Meister A. Selective modification of glutathione metabolism. Science. 220:1983;472-477.
5. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 30:1995;445-600.
6. Mannervik B, Awasthi YC, Board PG, Hayes JD, Di Ilio C, Ketterer B, Listowsky I, Morgenstern R, Muramatsu M, Pearson WR, et al. Nomenclature for human glutathione transferases. Biochem J. 282:1992;305-308.
7. McQuaid S, O'Brien A, Butler MR, Humphries P. Transcriptional activation of the glutathione S-transferase pi gene in human ureteric and bladder carcinomas. Cancer Lett. 39:1988;209-216.
8. Moscow JA, Fairchild CR, Madden MJ, Ransom DT, Wieand HS, O'Brien EE, Poplack DG, Cossman J, Myers CE, Cowan KH. Expression of anionic glutathione S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 49:1989;1422-1428.
9. Lafuente A, Giralt M, Cervello I, Pujol F, Mallol J. Glutathione-S-transferase activity in human superficial transitional cell carcinoma of the bladder. Comparison with healthy controls. Cancer. 65:1990;2064-2068.
10. Giralt M, Lafuente A, Pujol F, Mallol J. Enhanced glutathione S-transferase activity and glutathione content in human bladder cancer. Followup study: influence of smoking. J Urol. 149:1993;1452-1454.
11. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. J Biol Chem. 249:1974;7130-7139.
12. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem. 150:1985;76-85.
13. Peters WHM, Jansen PLM. Immunocharacterization of UDP-glucuronyltransferase isoenzymes in human liver, intestine and kidney. Biochem Pharmacol. 37:1988;564-567.
14. Peters WHM, Nagengast FM, Wobbes T. Glutathione S-transferases in normal and cancerous human colon tissue. Carcinogenesis. 10:1989;2371-2374.
15. Peters WHM, Kock L, Nagengast FM, Roelofs HMJ. Immunodetection with a monoclonal antibody of glutathione S-transferase mu in patients with and without carcinomas. Biochem Pharmacol. 39:1990;591-597.
16. Peters WHM, Boon CEW, Roelofs HMJ, Wobbes T, Nagengast FM, Kremers PG. Expression of drug metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology. 103:1992;448-455.
17. Singh SV, Roberts B, Gudi VA, Ruiz P, Awasthi YC. Immunohistochemical localization, purification and characterization of human urinary bladder glutathione S-transferases. Biochim Biophys Acta. 1074:1991;363-370.
18. Corrigall AV, Kirsch RE. Glutathione-S-transferase distribution and concentration in human organs. Biochem Int. 16:1988;443-448.
19. Terrier P, Townsend AJ, Coindre JM, Triche TJ, Cowan KH. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol. 137:1990;845-853.
20. Singh SV, Ahmad H, Krishan A. Expression of glutathione related enzymes in human bladder cancer cell lines. Biochem Pharmacol. 39:1990;1817-1820.
21. Ahn H, Lee E, Kim K, Lee C. Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines. J Urol. 151:1994;263-267.
22. Hirata S, Odajima T, Kohama GI, Ishigaki S, Niitsu Y. Significance of glutathione S-transferase-π as a tumor marker in patients with oral cancer. Cancer. 70:1992;2381-2387.
23. Niitsu Y, Takahashi Y, Saito T, Hirata Y, Arisato N, Maruyama H, Kohgo Y, Listowsky I. Serum glutathione S-transferase π as a tumor marker for gastrointestinal malignancies. Cancer. 63:1989;317-323.
24. Hao XY, Castro VM, Bergh J, Sundström, Mannervik B. Isoenzyme-specific quantitative immunoassays for cytosolic glutathione transferases and measurement of the enzymes in blood plasma from cancer patients and in tumour cell lines. Biochim Biophys Acta. 1225:1994;223-230.
25. Tsuchida S, Sato K. Glutathione S-transferases and cancer. Crit Rev Biochem Mol Biol. 27:1992;337-384.
26. Berhane K, Hao XY, Egyhazi S, Hansson J, Ringborg U, Mannervik B. Contribution of glutathione S-transferase M3-3 to 1,3-bis(chloroethyl)-1-nitrosurea resistance in a human non-small lung cancer cell line. Cancer Res. 53:1993;4257-4261.
27. Hao XY, Widersten M, Ridderström, Hellman U, Mannervik B. Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells; establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme. Biochem J. 297:1994;59-67.
28. Peters WHM, Wobbes T, Roelofs HMJ, Jansen JBMJ. Glutathione, glutathione S-transferases and P-170 glycoprotein in metastases of malignant melanomas. Int J Oncol. 14:1994;1323-1327.
29. Seidegard J, Pero RW. The hereditary transmission of high glutathione transferase activity towards transstilbene oxide in human mononuclear leucocytes. Hum Genet. 69:1985;66-68.
30. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ. Isoenzyme(s) of glutathione transferase (class mu) as a marker for susceptibility to lung cancer: a follow up study. Carcinogenesis. 11:1990;33-36.
31. Strange RC, Matharoo B, Faulder GC, Jones P, Cotton W, Elder JB, Deakin M. The human glutathione S-transferases: a case control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis. 12:1991;25-28.
32. Brockmöller J, Kerb R, Drakoulis N, Nitz M, Roots I. Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls. Cancer Res. 53:1993;1004-1011.
33. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst. 85:1993;1159-1164.
34. Brockmöller J, Kerb R, Drakoulis N, Staffeldt B, Roots I. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case control study. Cancer Res. 54:1994;4103-4111.
35. Brockmöller J, Kerb R, Roots I. Polymorphic glutathione S-transferases M1 (GSTM1A and B) and T1 (GSTT1) as modulators of bladder cancer susceptibility. ISSX Proceedings. 7:1995;26 International Society for the Study of Xenobiotics, Bethesda, Md.
36. Daly AK, Thomas DJ, Cooper J, Pearson W, Neal DE, Idle JR. Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer. Br Med J. 307:1993;481-482.
37. Lafuente A, Pujol F, Carretero P, Perez Villa J, Cuchi A. Human glutathione S-transferase μ (GSTμ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett. 68:1993;49-54.
38. Lin HJ, Han CY, Bernstein DA, Hsiao W, Lin BK, Hardy S. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer suceptibility. Carcinogenesis. 15:1994;1077-1081.
39. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis. 14:1993;1821-1824.
40. Silverman DT, Hartge P, Morrison AS, Devesa SS. Epidemiology of bladder cancer. Hematol Oncol Clin North Am. 6:1992;1-30.
41. Sorohan T, Lancashire RJ, Sole G. Urothelial cancer and cigarette smoking: findings from a regional case-controlled study. Br J Urol. 74:1994;753-756.
42. Robertson IGC, Guthenberg C, Mannervik B, Jernström B. Differences in stereoselectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutathione with 7β, 8α-dihydroxy-9α, 10α-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene. Cancer Res. 46:1986;2220-2224.
43. Townsend AJ, Cowan KH. Glutathione S-transferases and antineoplastic drug resistance. Cancer Bull. 41:1989;31-37.
44. Board P, Coggan M, Johnston P, Ross V, Suzuki T, Webb G. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther. 48:1990;357-369.
45. Schecter RL, Alaoui-Jamali MA. Glutathione S-transferase in chemotherapy resistance and in carcinogenesis. Biochem Cell Biol. 70:1992;349-353.
46. Xu BH, Gupta V, Singh SV. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance. Arch Biochem Biophys. 308:1994;164-170.
47. Perry RR, Greaves BR, Rasberry U, Barranco SC. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro. Cancer Res. 52:1992;4608-4612.